Steep Hill Opens Cannabis Testing and Analytics Lab In Albuquerque, New Mexico
09/16/2015
"Since New Mexico's passage of medical cannabis regulations in 2007, the state's medical cannabis market has become highly accessible to patients. The regulatory requirements being implemented by New Mexico are of the highest caliber and now assure that patients can access safe, tested, and efficacious medicinal cannabis products,” Steep Hill CEO David Lampach said, “This is a real breakthrough for New Mexico that other states will draw inspiration from as they consider regulation in the future."
According to the firm, “Steep Hill is working with regulators to move from provisional approval to a fully operational license over the next several weeks for the various analyses required by the State. Steep Hill is using state-of-the-art testing equipment at its Albuquerque lab to screen medical cannabis for various active components as well as potentially harmful micro-biological contaminants.”
Steep Hill's equipment is validated by international accrediting organizations and by Steep Hill's internal experts, company officials said. Over the next several months, the lab will add residual solvent and mycotoxin screening as required under NMAC 7.34, with other toxin screens coming, as well.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024